Smoking Cessation Interventions; Pharmacological Aids |
||
9. Bohadana AB, Nilsson F, Rasmussen T, Martinet Y . Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomised, double-blind, placebo-controlled trial. Arch Intern Med. 2000;160(20): 3128-3134. 10. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustainedrelease bupropion, a nicotine patch, or both for smoking cessation. New Engl J Med 1999;340(9): 685-691. 11. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG et al. The safety of transdermal nicotine as an aid to smoking cessation inpatients with cardiac disease. New Engl J Med.1996; 335:1792-1798. 12. ASH Scotland and Health Education Board for Scotland .Smoking cessation guidelines for Scotland. (2000). http://www.hebs.scot.nhs.uk/publics/pdf/SmokeGuidelines.pdf 13. Ogburn PL Jr., Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: Nicotine and cotinine levels and fetal effects Am J Obstet Gynecol.1999;181(3): 736-743. 14. Hopkins D, Briss P, Ricard CJ, Husten CG, Carande-Kulis VG, Fielding JE, et al. Task Force on Community Preventive Services.Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001 ;20(2 Suppl):16-66. 15. Hughes JR, Stead LF, Lancaster T. Anxiolytics and antidepressants for smoking cessation . Cochrane Database of Systematic Reveiws. 1, 2003. 16. Cheer SM, Goa KL. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs.2001; 61(1): 81-110. 17. Spring B, Wurtman J, Wurtman R,el-Khoury A, Goldberg H,McDermott J, et al. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain in smoking cessation. Am J Clin Nutr. 1995 Dec;62(6):1181-7. 18. Niaura R, Goldstein M, Spring B, Keuthen N, Kristeller J, DePue J et al. Fluoxetine for smoking cessation: A multicenter randomised double blind dose reponse study. The Society of Behavioral Medicine--18th annual meeting. Ann Behav Med. 1997;19 Suppl: S30-220. |
19. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, Mizes JS, Segraves KA, Kristeller JL, Xu W. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol.1999; 67(4): 547-554. 20. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation . Cochrane Database of Systematic Reveiws. 1, 2003. 21. Lancaster T,Stead LF. Mecamylamine ( a nicotine antagonist) for smoking cessation. Cochrane Database of Systematic Reveiws. 1, 2003. 22. Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD. A randomized trial of Naltrexone for smoking cessation. Addiction .1999 ;94(8) : 1227 -1237. 23. David S,Lancaster T,Stead LF. Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reveiws. 1, 2003. 24. HughesLancaster T,Stead LF. Anaxiolytics for smoking cessation. Cochrane Database of Systematic Reveiws. 1, 2003. 25. Lancaster T,Stead LF. Silver acetate for smoking cessation. Cochrane Database of Systematic Reveiws. 1, 2003. 26. White A, Resch KL, Ernst E. A meta-analysis of acupuncture techniques for smoking cessation. Tobacco Control.1999; 8(4): 393-397. 27. White A, Resch KL, Ernst E. Acupuncture for smoking cessation. Cochrane Database of Systematic Reveiws. 1, 2003. 28. Spiegel D, Frischholz EJ, Fleiss JL, Spiegel H. Predictors of smoking abstinence following a single-session restructuring intervention with self-hypnosis. Am J Psychiatry.1993; 150: 1090-1097. 29. Abbot NC, Stead LF, White AR, Barnes J, Ernst E. Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews. 1, 2003. 30. Green JP, Lynn SJ. Hypnosis and suggestion-based approaches to smoking cessation: An examination of the evidence. Int J Clin Exp Hypn.2000; 48(2): 195-224. |